SCHEMBL12263289

SCHEMBL12263289

Cn1cccc(-c2ccc(C(=O)O)cc2)c1=O

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HPGD P15428 1/20 0.46
ITGB1 P05556 3/20 0.44
ITGA4 P13612 3/20 0.44
CA12 O43570 1/20 0.44
CA1 P00915 1/20 0.44
CA2 P00918 1/20 0.44
CA9 Q16790 1/20 0.44
SCN2A Q99250 1/20 0.44
ITGB7 P26010 1/20 0.43
RXRA P19793 4/20 0.41
RARB P10826 1/20 0.41
RARG P13631 1/20 0.41
HRH3 Q9Y5N1 1/20 0.41
RXRB P28702 3/20 0.41
NR1H4 Q96RI1 1/20 0.40
EP300 Q09472 1/20 0.40
KAT8 Q9H7Z6 1/20 0.40
RXRG P48443 1/20 0.40
FOLH1 Q04609 1/20 0.40
TP53 P04637 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12263288 0.83 SMN1; SMN2 (0.50) HPGDITGB1ITGA4CA12CA1
SCHEMBL11575773 0.82 KDM4E (0.54) ITGB1ITGA4ITGB7HRH3KDM4E
SCHEMBL12987761 0.81 HRH3 (0.43) HPGDITGB1ITGA4ITGB7HRH3
SCHEMBL2398404 0.77 ITGB1 (0.47) HPGDITGB1ITGA4CA12CA1
SCHEMBL12263451 0.77 ITGB1 (0.47) HPGDITGB1ITGA4ALDH1A1JAK2
SCHEMBL12263453 0.76 SCN1A (0.46) HPGDITGB1ITGA4SCN2AHRH3
SCHEMBL12263261 0.75 HPGD (0.44) HPGD
SCHEMBL12263336 0.75 ITGB1 (0.46) HPGDITGB1ITGA4RXRAFOLH1
SCHEMBL12263299 0.75 ITGB1 (0.46) HPGDITGB1ITGA4SCN2ANR1H4
SCHEMBL23512903 0.75 HRH3 (0.44) ITGB1ITGA4ITGB7HRH3KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8022208-B2 Benzene derivative or salt thereof ASTELLAS PHARMA INC. (JP) 2011-09-20 US disclosed
US-8022208-B2 Benzene derivative or salt thereof ASTELLAS PHARMA INC. (JP) 2011-09-20 US disclosed
US-20090054352-A1 BENZENE DERIVATIVE OR SALT THEREOF ASTELLAS PHARMA INC. (JP) 2009-02-26 US disclosed
US-20090054352-A1 BENZENE DERIVATIVE OR SALT THEREOF ASTELLAS PHARMA INC. (JP) 2009-02-26 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090054352-A1 BENZENE DERIVATIVE OR SALT THEREOF F12, F2, SERPINC1 HPGD 582/4885ITGB1 3030/4885ITGA4 3624/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.